A phase II study of cisplatin, etoposide and gemcitabine in an unfavourable group of patients with carcinoma of unknown primary site

Annals of Oncology

Volumn 14, Issue 9, 2003, Pages 1425-1429

  Balana C ^a   Manzano, J L ^a   Moreno, I ^b   Cirauqui, B ^a   Abad, A ^a   Font, A ^a   Mate, J L ^a   Rosell, R ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b Hospital Municipal de Badalona   (Spain)

Author keywords

Chemotherapy; Gemcitabine; Unknown primary site

Indexed keywords

ANTIMETABOLITE; CISPLATIN; DEXAMETHASONE; ERYTHROPOIETIN; ETOPOSIDE; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MANNITOL; ONDANSETRON;

ADENOCARCINOMA; ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ARTICLE; ASTHENIA; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CARCINOMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG RESPONSE; FEBRILE NEUTROPENIA; FEMALE; HEARING LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; LEUKOPENIA; LIVER TOXICITY; MALE; NAUSEA AND VOMITING; NEUTROPENIA; PANCREAS CARCINOMA; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STOMATITIS; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TUMOR LOCALIZATION; WEIGHT REDUCTION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CISPLATIN; DEOXYCYTIDINE; ETOPOSIDE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY;

EID: 0141836849     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdg361     Document Type: Article

References (28)

1. Baron PL, Moore MP, Kinne SW et al. Occult breast cancer presenting with axillary metastases. Updated management. Arch Surg 1990; 125: 210-214.
2. Ellerbroek N, Holmes F, Singletary E et al. Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin. Cancer 1990; 66: 1461-1467.
3. Strand C, Grosh WW, Baxter JW. Peritoneal carcinomatosis of unknown primary site in women. Ann Intern Med 1989; 111: 213-217.
4. Hainsworth JD, Dial TW, Greco FA. Curative combination chemotherapy for patients with advanced poorly differentiated carcinoma of unknown primary site. Am J Clin Oncol 1988; 11: 138-145.
5. Nguyen C, Shenouda G, Black MJ et al. Metastatic squamous cell carcinoma to cervical lymph nodes from unknown primary mucosal sites. Head Neck 1994; 16: 58-63.
6. Wang RC, Goepfert H, Barber AE, Wolf P. Unknown primary squamous cell carcinoma metastatic to the neck. Arch Otolaryngol Head Neck Surg 1990; 116: 1388-1393.
7. Abbruzzese JL, Abbruzzese MC, Lenzi R et al. Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol 1995; 13: 2094-2103.
8. Le Chevalier T, Cvitkovic E, Caille P et al. Early metastatic cancer of unknown primary origin at presentation: a clinical study of 302 consecutive autopsied patients. Arch Intern Med 1988; 148: 2035-2039.
9. Hainsworth JD, Johnson DH, Greco FA. Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinorna of unknown primary site. Results of a 12-year experience. J Clin Oncol 1992; 10: 912-922.
10. Warner E, Goel R, Chang J et al. A multicentre phase II study of carboplatin and prolonged oral etoposide in the treatment of cancer of unknown primary site. Br J Cancer 1998; 77: 2376-2380.
11. Voog E, Merrouche Y, Trillet-Lenoir V et al. Multicentric phase II study of cisplatin and etoposide in patients with metastatic carcinoma of unknown primary. Am J Clin Oncol 2000; 23: 614-616.
12. Hainsworth JD, Erland JB, Kalman LA et al. Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin and extended schedule etoposide. J Clin Oncol 1997; 15: 2385-2393.
13. Kelly K. The role of single-agent gemcitabine in the treatment of non-small-cell lung cancer. Ann Oncol 1999; 10 (Suppl 5): 53-56.
14. Manegold C, Bergman B, Chemaissani A et al. Single-agent gemcitabine versus cisplatin-etoposide: early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer. Ann Oncol 1997; 8: 525-529.
15. Rothenberg MI, Moore MJ, Cripps MC et al. A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol 1996; 7: 347-353.
16. Burris HA, Moore MJ, Andersen J et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997; 15: 2403-2413.
17. Scheithauer W. Review of gemcitabine in biliary tract carcinoma. Semin Oncol 2002; 29: 40-45.
18. Hess KR, Abbruzzese MC, Lenzi R et al. Classification and regression tree analysis of 1000 consecutive patients with unknown primary carcinoma. Clin Cancer Res 1999; 5: 3403-3410.
19. Greco FA, Burris HA, Erland JB et al. Carcinoma of unknown primary site. Long term follow-up after treatment with paclitaxel, carboplatin and etoposide. Cancer 2000; 89: 2655-2660.
20. Briasoulis E, Kalofonos H, Bafaloukos D et al. Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study. J Clin Oncol 2000; 18: 3101-3107.
21. Lastra E, Muñoz A, Rubio I et al. Paclitaxel, carboplatin and oral etoposide in the treatment of patients with cancer of unknown primary site. Proc Am Soc Clin Oncol 2000; 19: 579a (Abstr 2279C).
22. Elkordy M, Berrry W, Khan M et al. A Phase II study of weekly paclitaxel (taxol) and carboplatin in advanced carcinoma of unknown primary origin. Proc Am Soc Clin Oncol 2001; 20: 402a (Abstr 1603).
23. Greco FA, Erland JB, Morrissey LH et al. Carcinoma of unknown primary site: phase II trials with docetaxel plus cisplatin or carboplatin. Ann Oncol 2000; 11: 211-215.
24. Hainsworth JD, Burris HA, Calvert SW et al. Gemcitabine in the secondline therapy of patients with carcinoma of unknown primary site: a phase II trial of the Minnie Pearl Cancer Research Network. Cancer Invest 2001; 19: 335-339.
25. Greco FA, Burris HA, Litchy S et al. Gemcitabine, carboplatin and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network Study. J Clin Oncol 2002; 20: 1651-1656.
26. Ayoub JP, Hess KR, Abbruzzese R et al. Unknown primary tumors metastatic to liver. J Clin Oncol 1998; 16: 2105-2112.
27. Earle CC, Stewart DJ, Cormier Y et al. A phase I study of gemcitabine/ cisplatin/etoposide in the treatment of small-cell lung cancer. Lung Cancer 1998; 22: 235-241.
28. Dennis JL, Vass JK, Wit EC et al. Identification from public data of molecular markers of adenocarcinoma characteristics of the site of origin. Cancer Res 2002; 62: 5999-6005.